Chris Elliott Fund

Entries for the ‘News’ Category

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

The study is a prospective, randomly controlled pivotal trial, designed to test the efficacy and safety of a medical device, the NovoTTF-100A, as an adjuvant to the best standard of care in the treatment of newly diagnosed GBM patients. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields [...]

AMANDA’S TESTIMONY: SOLID ADVICE

“When my son was first diagnosed with a GBM, we were scared but determined to fight. We started searching for answers on the internet right away, and as you can imagine, we found a lot of bad information along with a lot of good information. It was hard to tell what was good advice and [...]

SEEKING CORPORATE SUPPORT AS CEF EXPANDS ITS REACH & SERVICE

You have been following all of it here on FaceBook. The testimoney and the FDA hearings back in March and then, just a few days ago last month, the Chris Elliott Fund (CEF) and I were honored at the National Brain Tumor Society’s Annual Mtg. & Summit/Conference in Philadelphia, specifically for the quality and thoroughness of the [...]

The Gift of Life and Hope

As we partake in the celebration and festivities of this holiday season, I would like to take a moment and remind all of our Facebook friends that brain cancer does not take a holiday.  Neither does the need for support and advocacy for brain tumor patients.   At the Chris Elliott Fund, we like to think [...]

IMPORTANCE OF HAVING ACCES TO CREDIBLE SOURCES OF INFORMATION

In my own personal journey through cancer, the thing that surprised me the most was the well-meaning advice of friends that could have killed me had I been naive enough to follow it. This includes the myriad of questionable information out there on the internet, especially miracle cures and “natural treatments”. These range from “juice [...]